Bellevue Life Sciences Acquisition Corp.
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Bellevue Life Sciences Acquisition Corp.'s balance sheet done over the years? Its assets were worth $36,627,733 last year, which is more than in the previous period. 11% of Bellevue Life Sciences Acquisition Corp.’s total assets is currently financed by debt. Its liabilities reached the amount of $4,108,272, which means an increase by 225% compared compared to last year.

Debt to Assets

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Debt to assets
2020 322749 321.56K 99.63%
2021 705087 707.20K 100.3%
2022 1225854 1.26M 103.06%
2023 36627733 4.10M 11.22%

BLAC Balance Sheet (2020 – 2023)

2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
15.41K124.50K4.75K62.65K
Short term investments
0000
Net receivables
0000
Inventory
0000
Other current assets
7.20K000
Total current assets
22.62K124.50K4.75K62.65K
Non-current assets:
Property, Plant and Equipment
0000
Goodwill
0000
Intangible assets
0000
Long term investments
36.60M000
Other non-current assets
01.10M700.33K260.09K
Total non-current assets
36.60M1.10M700.33K260.09K
Total assets
36.62M1.22M705.08K322.74K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000
Short term debt
01.2M400K300K
Total current liabilities
2.03M1.26M707.20K321.56K
Non-current liabilities:
Long term debt
0000
Deferred tax
0000
Other non-current liabilities
2.07M1.23M00
Total non-current liabilities
2.07M1.23M00
Total liabilities
4.10M1.26M707.20K321.56K
Data sourceData source